Tarsus Pharmaceuticals Inc
NASDAQ:TARS
During the last 3 months Tarsus Pharmaceuticals Inc insiders have not bought any shares, and sold 1.3m USD worth of shares. The stock price has dropped by 6% over this period (open performance analysis).
The last transaction was made on
Mar 24, 2025
by
Azamian Bobak R.
(President and Chief Executive Officer)
, who
sold
300k USD
worth of TARS shares.
During the last 3 months Tarsus Pharmaceuticals Inc insiders have not bought any shares, and sold 1.3m USD worth of shares. The stock price has dropped by 6% over this period (open performance analysis).
The last transaction was made on
Mar 24, 2025
by
Azamian Bobak R.
(President and Chief Executive Officer)
, who
sold
300k USD
worth of TARS shares.
Tarsus Pharmaceuticals Inc
Glance View
Tarsus Pharmaceuticals Inc. emerged as a dynamic player in the biotech landscape, primarily driven by its innovative approach to addressing unmet medical needs in ocular health. The company gained attention for its work on developing therapeutic solutions for conditions with significant market potential but limited existing treatments. With a focused approach on tackling Demodex blepharitis, an inflammation of the eyelids caused by a common parasitic mite, Tarsus developed TP-03, an innovative product spearheading its advancement in ocular therapeutics. This biopharmaceutical firm's strategy revolves around capitalizing on its scientific expertise to create niche products that cater to specific, underserved segments, aiming for leadership in targeted therapeutic areas. Tarsus Pharmaceuticals relies on the successful commercialization of its treatments to generate revenue, which primarily comes from sales and partnerships. By shepherding its products through clinical trials and securing regulatory approvals, Tarsus positions itself competitively in the pharmaceutical market. Its business model is centered on developing specialized treatments that fill gaps overlooked by larger pharmaceutical companies, allowing it to carve out a unique space in the industry. Furthermore, by building strategic alliances and leveraging partnerships, Tarsus enhances its capabilities for broader distribution and market penetration, thus ensuring sustainable growth and fostering innovation in therapeutic solutions.
What is Insider Trading?
Insider trading refers to the buying or selling of a company’s stock by individuals with access to non-public, material information about the company.
While legal insider trading occurs when insiders follow disclosure rules, illegal insider trading involves trading based on confidential information and is prohibited by law.
Why is Insider Trading Important?
It isn't a coincidence that corporate executives seem to always buy at the right times. After all, they have access to every bit of company information you could ever want.
However, the fact that company executives have unique insights doesn't mean that individual investors are always left in the dark. Insider trading data is out there for all who want to use it.
Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
You don't have any saved screeners yet